Current Neuro-Oncology
Volume
7 Number 10
31 October 2005
Home > Publications > Current Neuro-Oncology > Volume 7, Year 2005 > Number 10, 31 October
Wemmert S, Ketter R, Rahnenführer
J, Beerenwinkel N, Strowitzki M, Feiden W, Hartmann C, Lengauer T,
Stockhammer F, Zang KD, Meese E, Steudel WI, von Deimling A,
Urbschat S.
Patients
with high-grade gliomas harboring deletions of chromosomes 9p and
10q benefit from temozolomide treatment.
Neoplasia.
2005 Oct;7(10):883-93∟.
doi: 10.1593/neo.05307∟.
PMID: 16242071∟.
Observational study. ˍ
Giordana MT, D'Agostino C, Pollo B,
Silvani A, Ferracini R, Paiolo A, Ghiglione P, Chiò
A.
Anaplasia
is rare and does not influence prognosis in adult
medulloblastoma.
J
Neuropathol Exp Neurol. 2005 Oct 1;64(10):869-74∟.
doi: 10.1097/01.jnen.0000182980.64236.01∟.
PMID: 16215458∟.
Observational study. ˍ
*
Heese O, Disko A, Zirkel D,
Westphal M, Lamszus K.
Neural
stem cell migration toward gliomas in vitro.
Neuro
Oncol. 2005 Oct 1;7(4):476-84∟.
doi: 10.1215/S1152851704000754∟.
PMID: 16212812∟.
Laboratory investigation. ˍ
Hsieh PC, Chandler JP, Bhangoo S,
Panagiotopoulos K, Kalapurakal JA, Marymont MH, Cozzens JW, Levy
RM, Salehi S.
Adjuvant
gamma knife stereotactic radiosurgery at the time of tumor
progression potentially improves survival for patients with
glioblastoma multiforme.
Neurosurgery.
2005 Oct 1;57(4):684-92∟.
doi: 10.1227/01.NEU.0000175550.96901.A3∟
PMID: 16239880∟.
Observational study. ˍ
Leimgruber A, Ostermann S, Yeon EJ,
Buff E, Maeder PP, Stupp R, Meuli RA.
Perfusion
and diffusion MRI of glioblastoma progression in a four-year
prospective temozolomide clinical trial.
Int
J Radiat Oncol Biol Phys. 2005 Oct 13;64(3):869-75∟.
doi: 10.1016/j.ijrobp.2005.08.015∟.
PMID: 16226399∟.
Interventional study. ˍ
Brandes AA.
Adding temozolomide to
radiotherapy prolongs survival in people with glioblastoma.
Cancer
Treat Rev. 2005 Oct 19;31(7):577-81∟.
doi: 10.1016/j.ctrv.2005.08.004∟.
PMID: 16242242∟.
Interventional study. ˍ
Abstracted
from: Stupp
R, Mason WP, van
den Bent MJ,
et
al. Radiotherapy plus concomitant and adjuvant temozolomide for
glioblastoma.
N Engl J Med. 2005 Mar 10;352(10):987-96∟.
doi: 10.1056/NEJMoa043330∟.
PMID: 15758009∟.
Interventional study. ˍ
Douglas JG, Stelzer KJ, Mankoff DA, Tralins KS, Krohn KA, Muzi M,
Silbergeld DL, Rostomily RC, Scharnhorst J, Spence
AM.
[F-18]-fluorodeoxyglucose positron
emission tomography for targeting radiation dose escalation for
patients with glioblastoma multiforme: clinical outcomes and
patterns of failure.
Int J Radiat Oncol Biol Phys.
2005 Oct 19;64(3):886-91∟.
doi: 10.1016/j.ijrobp.2005.08.013∟.
PMID: 16242251∟.
Interventional study. ˍ
Geyer JR, Sposto R, Jennings M,
Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL,
Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R,
Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T; Children's
Cancer Group.
Multiagent
chemotherapy and deferred radiotherapy in infants with malignant
brain tumors: a report from the Children's Cancer Group.
J
Clin Oncol. 2005 Oct 20;23(30):7621-31∟.
doi: 10.1200/JCO.2005.09.095∟.
PMID: 16234523∟.
Interventional study. ˍ
*
McNally RJ, Eden TO, Alexander FE,
Kelsey AM, Birch JM.
Is
there a common aetiology for certain childhood malignancies?
Results of cross-space-time clustering analyses.
Eur
J Cancer. 2005 Oct 21;41(18):2911-6∟.
doi: 10.1016/j.ejca.2005.04.051∟.
PMID: 16243517∟.
Observational study. ˍ